Mallinckrodt Challenge Says FDA Overstepped Bounds

08.06.2015 - An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...